Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Farmers Insurance
Deloitte
Novartis
McKesson
Express Scripts
US Army
UBS
Medtronic

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,173,037

« Back to Dashboard

Which drugs does patent 7,173,037 protect, and when does it expire?


Patent 7,173,037 protects ADEMPAS and is included in one NDA.

This patent has forty-one patent family members in thirty-five countries.

Summary for Patent: 7,173,037

Title:Carbamate-substituted pyrazolopyridines
Abstract: The present invention relates to compounds which stimulate soluble guanylate cyclase, to the preparation thereof and to the use thereof as medicaments, in particular as medicaments for the treatment of cardiovascular disorders and/or sexual dysfunction.
Inventor(s): Alonso-Alija; Cristina (Haan, DE), Bischoff; Erwin (Wuppertal, DE), Munter; Klaus (Wulfrath, DE), Stasch; Johannes-Peter (Solingen, DE), Stahl; Elke (Gladbach, DE), Weigand; Stefan (Wuppertal, DE), Feurer; Achim (Wilhelmsfeld, DE)
Assignee: Bayer HealthCare AG (Leverkusen, DE)
Application Number:10/513,869
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-001Oct 8, 2013RXYesNo► Subscribe► SubscribeYY
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-002Oct 8, 2013RXYesNo► Subscribe► SubscribeYY
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-003Oct 8, 2013RXYesNo► Subscribe► SubscribeYY
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-004Oct 8, 2013RXYesNo► Subscribe► SubscribeYY
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-005Oct 8, 2013RXYesYes► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,173,037

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 20 570May 8, 2002
PCT Information
PCT FiledApril 25, 2003PCT Application Number:PCT/EP03/04304
PCT Publication Date:November 20, 2003PCT Publication Number: WO03/095451

International Patent Family for Patent: 7,173,037

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1665811► Subscribe
China1330649► Subscribe
Cuba23453► Subscribe
Germany10220570► Subscribe
Germany50303960► Subscribe
Denmark1506193► Subscribe
Dominican RepublicP2003000639► Subscribe
EcuadorSP045414► Subscribe
European Patent Office1506193► SubscribeC01506193/01Switzerland► Subscribe
European Patent Office1506193► SubscribePA2014018,C1506193Lithuania► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Healthtrust
Merck
Cerilliant
Chubb
Chinese Patent Office
Federal Trade Commission
Colorcon
Novartis
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot